血小板
止血
血栓
凝结
凝血酶
基因剔除小鼠
血栓形成
纤维蛋白
磷脂酰丝氨酸
医学
血小板活化
巨核细胞
内科学
化学
免疫学
细胞生物学
磷脂
受体
生物
膜
生物化学
造血
干细胞
作者
Ayesha Baig,Elizabeth J. Haining,Eva Geuß,Sarah Beck,Frauke Swieringa,Podchanart Wanitchakool,Michael K. Schuhmann,David Stegner,Karl Kunzelmann,Christoph Kleinschnitz,Johan W. M. Heemskerk,Attila Braun,Bernhard Nieswandt
标识
DOI:10.1161/atvbaha.116.307727
摘要
It is known that both platelets and coagulation strongly influence infarct progression after ischemic stroke, but the mechanisms and their interplay are unknown. Our aim was to assess the contribution of the procoagulant platelet surface, and thus platelet-driven thrombin generation, to the progression of thromboinflammation in the ischemic brain.We present the characterization of a novel platelet and megakaryocyte-specific TMEM16F (anoctamin 6) knockout mouse. Reflecting Scott syndrome, platelets from the knockout mouse had a significant reduction in procoagulant characteristics that altered thrombin and fibrin generation kinetics. In addition, knockout mice showed significant defects in hemostasis and arterial thrombus formation. However, infarct volumes in a model of ischemic stroke were comparable with wild-type mice.Platelet TMEM16F activity contributes significantly to hemostasis and thrombosis but not cerebral thromboinflammation. These results highlight another key difference between the roles of platelets and coagulation in these processes.
科研通智能强力驱动
Strongly Powered by AbleSci AI